# Comparison of Two Etoposide Initiation Strategies for Severe Hemophagocytic Lymphohistiocytosis

> **NCT07497438** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 176 (estimated)

## Conditions studied

- Hemophagocytic Lymphohistiocytosis

## Interventions

- **DRUG:** Etoposide (Early strategy)
- **DRUG:** Etoposide (Delayed strategy)

## Key facts

- **NCT ID:** NCT07497438
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2029-12
- **Final completion:** 2030-02
- **Target enrollment:** 176 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07497438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07497438, "Comparison of Two Etoposide Initiation Strategies for Severe Hemophagocytic Lymphohistiocytosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07497438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*